Results 11 to 20 of about 92,115 (273)

Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study [PDF]

Gastroenterology Research and Practice, 2017
Aims. To compare the surgical and oncological outcomes of rectal mucinous adenocarcinomas treated with neoadjuvant chemoradiotherapy versus surgery alone. Methods.
Yan-wu Sun, Pan Chi, Hui-ming Lin, Xing-rong Lu, Ying Huang, Zong-bin Xu, Sheng-hui Huang, Xiao-jie Wang   +7 more
doaj   +2 more sources

Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study

Clinical and Translational Radiation Oncology, 2023
Background: Complications after esophagectomy are common and the possible increase in postoperative complications associated with neoadjuvant chemoradiotherapy is of concern.
Halla Sif Ólafsdóttir, Emmy Dalqvist, Eva Onjukka, Fredrik Klevebro, Magnus Nilsson, Giovanna Gagliardi, Gabriella Alexandersson von Döbeln   +6 more
doaj   +2 more sources

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER [PDF]

Сибирский онкологический журнал, 2018
Purpose. We analyzed the frequency and severity of hematologic, hepatic and pancreatic toxicity during and after completion of neoadjuvant chemoradiotherapy in patients with gastric cancer.Material and methods.
V. Yu. Skoropad, D. D. Kudryavtsev, E. N. Anikina, M. V. Poluaktova, L. N. Titova   +4 more
doaj   +2 more sources

NEOADJUVANT CHEMORADIOTHERAPY AND SURGERY COMPARED WITH SURGERY ALONE IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS

Arquivos de Gastroenterologia, 2013
Context Despite progress in recent years in methods of diagnosis and surgical treatment of esophageal cancer, there is still controversy about the benefits from neoadjuvant chemoradiotherapy.
Nelson Adami ANDREOLLO, Valdir TERCIOTI Jr., Luiz Roberto LOPES, João de Souza COELHO-NETO   +3 more
doaj   +2 more sources

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. [PDF]

PLoS ONE, 2018
BACKGROUND:The benefit of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy for treating cancer of the esophagus or the gastroesophageal junction remains controversial.
Xin Zhao, Yiming Ren, Yong Hu, Naiqiang Cui, Ximo Wang, Yunfeng Cui   +5 more
doaj   +2 more sources

Emerging insights on neoadjuvant chemoradiotherapy in pancreatic cancer [PDF]

, 2021
The overall survival of patients with resectable or borderline-resectable pancreatic ductal adenocarcinoma (PDAC) has hardly improved over the last decade with a rise in studies investigating the role of preoperative (neoadjuvant) chemoradiotherapy ...
Versteijne, E.
core   +18 more sources

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study [PDF]

, 2023
International audienceAbstract Background The Mayo protocol for liver transplantation in patients with unresectable perihilar cholangiocarcinoma is based on strict selection and neoadjuvant chemoradiotherapy.
Boleslawski, Emmanuel, Kuipers, H., Dubbeld, Jeroen, Ijzermans, Jan N.M., Dubbeld, J., Polak, Wojciech, Alwayn, I.P.J., Muscari, F., Mabrut, J.Y., van Hoek, Bart, Hoogwater, F.J.H., van Vilsteren, Frederike, Kuipers, Hendrien; id_orcid, Alwayn, Ian P.J., Ijzermans, J.N.M., De Meijer, Vincent E.; id_orcid, de Meijer, Vincent, Porte, Robert, Polak, W.G., Rayar, Michel, Boleslawski, E., Muscari, Fabrice, Chebaro, Alexandre, Kuipers, Hendrien, Meijer, V.E. de, Porte, R.J., Rayar, M., Jezequel, C., De Meijer, Vincent E., Mabrut, Jean‐yves, Adam, J.P., Hoek, B. van, Mohkam, Kayvan, Van Vilsteren, Frederike G.I., Chebaro, A., Murad, Sarwa Darwish, Adam, Jean-Philippe, Alwayn, Ian, Vilsteren, F.G.I. van, Hoogwater, Frederik J.H., Hoogwater, Frederik, Maulat, C., Polak, Wojciech G.; id_orcid, Chiche, Laurence, Murad, S.D., Ijzermans, Jan, Mabrut, Jean Yves, Polak, Wojciech G., Chiche, L., Mohkam, K., Jézéquel, Caroline, Adam, Jean Philippe, Porte, Robert J., Maulat, Charlotte   +53 more
core   +1 more source

Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial

BMC Cancer, 2023
Background The failure rate after neoadjuvant chemoradiotherapy followed by surgery is approximately 34.6%–48% for resectable esophageal carcinoma. Pathologic complete response after neoadjuvant chemoradiotherapy is an important factor in predicting ...
Jinsong Yang, Ai Huang, Kunyu Yang, Ke Jiang   +3 more
doaj   +1 more source

Effects of Neoadjuvant Chemio-Radiation Therapy on the Anal Sphincter Function in Patients with Low Rectal Cancers

Креативная хирургия и онкология, 2020
The aim of the study was to compare functional results prior to and following neoadjuvant chemoradiation therapy.Materials and methods. An analysis of the functional results of a prospective clinical study was carried out.
A. B. Baichorov, A. O. Rasulov
doaj   +1 more source

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer [PDF]

, 2020
In locally advanced rectal cancer, neoadjuvant chemoradiotherapy provides a significant benefit to local cancer control in addition to total mesorectal excision.
Peros, Georgios, Lunger, Fabian
core   +1 more source